Abstract:In recent years, the application of advanced analytics, especially artificial intelligence (AI), to digital H&E images, and other histological image types, has begun to radically change how histological images are used in the clinic. Alongside the recognition that the tumour microenvironment (TME) has a profound impact on tumour phenotype, the technical development of highly multiplexed immunofluorescence platforms has enhanced the biological complexity that can be captured in the TME with high precision. AI has an increasingly powerful role in the recognition and quantitation of image features and the association of such features with clinically important outcomes, as occurs in distinct stages in conventional machine learning. Deep-learning algorithms are able to elucidate TME patterns inherent in the input data with minimum levels of human intelligence and, hence, have the potential to achieve clinically relevant predictions and discovery of important TME features. Furthermore, the diverse repertoire of deep-learning algorithms able to interrogate TME patterns extends beyond convolutional neural networks to include attention-based models, graph neural networks, and multimodal models. To date, AI models have largely been evaluated retrospectively, outside the well-established rigour of prospective clinical trials, in part because traditional clinical trial methodology may not always be suitable for the assessment of AI technology. However, to enable digital pathology-based advanced analytics to meaningfully impact clinical care, specific measures of 'added benefit' to the current standard of care and validation in a prospective setting are important. This will need to be accompanied by adequate measures of explainability and interpretability. Despite such challenges, the combination of expanding datasets, increased computational power, and the possibility of integration of pre-clinical experimental insights into model development means there is exciting potential for the future progress of these AI applications. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer

Artificial intelligence in digital histopathology for predicting patient prognosis and treatment efficacy in breast cancer

Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response

Artificial Intelligence in Breast Cancer Diagnosis and Treatment: Advances in Imaging, Pathology, and Personalized Care

Computational Methods for Breast Cancer Molecular Profiling through Routine Histopathology: A Review

Digital pathology and artificial intelligence in translational medicine and clinical practice

A Glimpse into the Future: Integrating Artificial Intelligence for Precision HER2‐positive Breast Cancer Management

Artificial intelligence's impact on breast cancer pathology: a literature review

Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence

Artificial intelligence in cancer imaging: Clinical challenges and applications

Deep learning in cancer pathology: a new generation of clinical biomarkers

Advancing personalized oncology: a systematic review on the integration of artificial intelligence in monitoring neoadjuvant treatment for breast cancer patients

Artificial Intelligence-Enabled Prostate Cancer Diagnosis and Prognosis: Current State and Future Implications

Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction

Artificial Intelligence in Colorectal Cancer: From Patient Screening over Tailoring Treatment Decisions to Identification of Novel Biomarkers

Advancements in Pancreatic Cancer Detection: Integrating Biomarkers, Imaging Technologies, and Machine Learning for Early Diagnosis

Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption

Emerging role of deep learning-based artificial intelligence in tumor pathology

Emerging Role of Deep Learning‐based Artificial Intelligence in Tumor Pathology

Artificial Intelligence for the Identification of Biomarkers in Cancer Prevention and Diagnosis: Advances and Perspectives

Deep learning, Artificial Intelligence and machine learning in cancer: Prognosis, diagnosis and treatment